ArticleAnnals of surgical oncology2024

Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial.

Monica N Khattak et al.PubMed ↗Publisher ↗

No numbers read from the abstract.